PBMs, insurers strike deals for Hep C drugs

Catamaran is the latest PBM to cut a deal for lower-priced hepatitis C treatments for its customers. At the beginning of February, Catamaran added Gilead Sciences' hepatitis C treatments, Harvoni and Sovaldi, to its national and value formularies, making these drug therapies the exclusive options for patients with hepatitis C. » Details

Formulary managers can help improve vaccination rates

Vaccine-preventable diseases have been top-of-mind from a public health perspective and politicized due to the recent measles outbreak that began in California and spread to Illinois. » Read more

Rite Aid buys PBM EnvisionRx

In a move widely seen as a way to better compete with the other major chain drugstores, Rite Aid Corp. has announced an agreement on Feb. 11 to buy the pharmacy benefits manager (PBM) EnvisionRx for about $2 billion. » More

IN CASE YOU MISSED IT

• Anthem hack exposes up to 80 million records

• Three game changers threaten the industry in 2015

• Irritable bowel syndrome therapeutics market dynamics

Keep in touch with MHE

We value your input. Please send your comments and article ideas to [email protected].